Cheju Halla General Hopsital
Jeju City, Jeju Special Governing Province, 670-744, South Korea
NCT Number: NCT02326948
This case-control study matched by age and sex was performed to evaluate the region specific risk factors for gallbladder cancer in Jeju island, Korea.
Looking for future studies?
Notify MeAll sexes
Observational
Jeju City, Jeju Special Governing Province, 670-744, South Korea
In order to estimate region-specific risk factors for gallbladder cancer (GBC) in Jeju island, Korea the investigators performed a case-control study. Among 124 GBC patients and 7088 health controls, the investigators randomly selected 78 cases and 78 age-sex matched controls (1:1 matching) and compared their demographic features, combined diseases, and personal histories about known risk factors until now.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 3 years
Time frame: Up to 3 year
Time frame: Up to 3 years
Cheju Halla General Hospital
Other
Alcohol Consumption and Gallbladder Cancer: Case-control Study in Jeju Island, Korea.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04871321
Adenocarcinoma, Biliary Tract Cancer
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT07092397
Biliary Tract Diseases, Biliary Tract Neoplasms
Seoul, South Korea
View Trial DetailsNCT05253053
Adenocarcinoma, Advanced Solid Tumor
Wuhu, Anhui, China
View Trial DetailsNCT04484636
Adenocarcinoma, Biliary Tract Diseases
Frankfurt am Main, Hesse, Germany
View Trial Details